News
Bird Flu Threat Still Looms, But HHS Just Canceled a Moderna Contract That Could Prepare for It
Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna’s vaccine candidate for avian influenza is on track for Phase 3 testing. But the Department of Health and Human Services has canceled a $590 million contract to support Moderna's pivotal trial.
HHS cancels funding for Moderna’s candidate H5 avian flu and pandemic vaccines
In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services (HHS) has terminated a $590 million award it received in January for late-stage development of a candidate mRNA vaccine against H5 avian influenza and the development of other prepandemic vaccine candidates.
Team Trump canceled a $770 mln contract with Moderna to develop an H5 vaccine. In a cost-benefit analysis, it’s a dangerous ...
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...
Pediatric patients exhibited high risk for severe avian influenza A/H5N1, suggesting clinical therapeutic and vaccine trials should be prioritized in this population.
Poultry at a second commercial farm in Maricopa County have tested positive for Avian Influenza, according to a report. The ...
News-Medical.Net on MSN6d
Experts explain how H5 avian influenza adapts to infect more animalsThe Gs/Gd lineage of highly pathogenic H5 avian influenza viruses—including H5N1—has rapidly evolved, spreading globally and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback